UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
science & technology (2390) 2390
humans (2326) 2326
life sciences & biomedicine (2194) 2194
adenine - analogs & derivatives (1819) 1819
male (1530) 1530
female (1267) 1267
tenofovir (1098) 1098
adenine - adverse effects (1033) 1033
adult (1009) 1009
adenine - therapeutic use (970) 970
middle aged (882) 882
hiv infections - drug therapy (795) 795
organophosphonates - adverse effects (776) 776
organophosphonates - therapeutic use (747) 747
infectious diseases (738) 738
biological and medical sciences (716) 716
animals (698) 698
medical sciences (676) 676
adenine - administration & dosage (554) 554
anti-hiv agents - adverse effects (547) 547
treatment outcome (518) 518
adenine (483) 483
organophosphonates - administration & dosage (444) 444
anti-hiv agents - therapeutic use (425) 425
antiviral agents (422) 422
pharmacology & pharmacy (420) 420
antiviral agents - therapeutic use (399) 399
drug therapy, combination (397) 397
hepatitis b, chronic - drug therapy (393) 393
viral diseases (386) 386
pharmacology. drug treatments (373) 373
aged (356) 356
adenine - pharmacology (355) 355
human viral diseases (346) 346
immunology (332) 332
hiv (321) 321
drug therapy (300) 300
virology (296) 296
anti-hiv agents - administration & dosage (289) 289
deoxycytidine - analogs & derivatives (289) 289
emtricitabine (284) 284
antibiotics. antiinfectious agents. antiparasitic agents (274) 274
antiviral agents - adverse effects (273) 273
lamivudine - therapeutic use (267) 267
aids/hiv (264) 264
rats (257) 257
health aspects (251) 251
nicotinamide adenine dinucleotide (250) 250
young adult (245) 245
human immunodeficiency virus--hiv (243) 243
adolescent (239) 239
hepatitis b (239) 239
viral diseases of the lymphoid tissue and the blood. aids (236) 236
reverse transcriptase inhibitors - adverse effects (233) 233
analysis (231) 231
research (229) 229
viral load (227) 227
risk factors (223) 223
time factors (222) 222
abridged index medicus (219) 219
gastroenterology & hepatology (217) 217
microbiology (216) 216
reverse transcriptase inhibitors - therapeutic use (210) 210
proteins (206) 206
mice (196) 196
medicine (193) 193
metabolism (191) 191
organophosphonates (190) 190
research article (190) 190
lamivudine (189) 189
oncology (188) 188
hematology (185) 185
science & technology - other topics (184) 184
antiretroviral drugs (182) 182
care and treatment (182) 182
multidisciplinary sciences (178) 178
hiv infection (176) 176
biochemistry & molecular biology (175) 175
drug resistance, viral (171) 171
guanine - analogs & derivatives (169) 169
deoxycytidine - therapeutic use (167) 167
clinical trials (163) 163
hiv infections - virology (161) 161
cell biology (159) 159
antiviral agents - administration & dosage (158) 158
drug combinations (156) 156
dosage and administration (155) 155
gene expression (154) 154
hiv infections - complications (154) 154
oxidative stress (154) 154
retrospective studies (154) 154
deoxycytidine - administration & dosage (152) 152
nicotinamide (150) 150
hiv-1 - drug effects (147) 147
adenine - pharmacokinetics (146) 146
mutation (145) 145
enzymes (144) 144
hepatitis b virus - drug effects (144) 144
deoxycytidine - adverse effects (142) 142
science (142) 142
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (3011) 3011
German (47) 47
Spanish (35) 35
Chinese (30) 30
French (29) 29
Japanese (23) 23
Russian (16) 16
Italian (5) 5
Polish (5) 5
Portuguese (5) 5
Korean (4) 4
Czech (2) 2
Dutch (2) 2
Hebrew (1) 1
Hungarian (1) 1
Norwegian (1) 1
Slovak (1) 1
Turkish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The Journal of infectious diseases, ISSN 0022-1899, 6/2011, Volume 203, Issue 12, pp. 1791 - 1801
HIV/AIDS | Percentage change | RNA | Spine | Bones | Bone density | Arm | Hip | Bone fractures | HIV 1 | Arts | Infectious Diseases | Immunology | Life Sciences & Biomedicine | Microbiology | Science & Technology | Fundamental and applied biological sciences. Psychology | Infectious diseases | Viral diseases | Viral diseases of the lymphoid tissue and the blood. Aids | Biological and medical sciences | Medical sciences | Human viral diseases | Humans | Middle Aged | Antiretroviral Therapy, Highly Active - adverse effects | Fractures, Bone - epidemiology | Male | Oligopeptides - adverse effects | Viral Load | Lamivudine - adverse effects | Tenofovir | Pyridines - adverse effects | Adenine - adverse effects | Ritonavir - adverse effects | Atazanavir Sulfate | Adult | Deoxycytidine - adverse effects | Female | Dideoxynucleosides - adverse effects | Drug Therapy, Combination | Emtricitabine | Adenine - analogs & derivatives | Osteoporosis - chemically induced | Anti-HIV Agents - adverse effects | Risk Factors | Organophosphonates - adverse effects | Benzoxazines - adverse effects | CD4 Lymphocyte Count | Absorptiometry, Photon | Bone Density - drug effects | HIV Infections - complications | Intention to Treat Analysis | HIV Infections - drug therapy | Fractures, Bone - chemically induced | Deoxycytidine - analogs & derivatives | Drug Combinations | Usage | Care and treatment | Ritonavir | Drug utilization | Lamivudine | Efavirenz | Prevention | Abacavir | Dosage and administration | Drug therapy, Combination | Drug therapy | HIV infection | Index Medicus | Abridged Index Medicus | Major and Brief Reports
Journal Article
The Lancet infectious diseases, ISSN 1473-3099, 2014, Volume 14, Issue 7, pp. 581 - 589
Infectious Disease | Life Sciences & Biomedicine | Infectious Diseases | Science & Technology | Antiviral agents | Immunopathology | Infectious diseases | Pharmacology. Drug treatments | Viral diseases | Viral diseases of the lymphoid tissue and the blood. Aids | Biological and medical sciences | Medical sciences | Human viral diseases | Immunodeficiencies. Immunoglobulinopathies | Immunodeficiencies | Antibiotics. Antiinfectious agents. Antiparasitic agents | Humans | Middle Aged | Male | Thiazoles - therapeutic use | Thiazoles - adverse effects | Tenofovir | Deoxycytidine - therapeutic use | Drug Therapy, Combination - adverse effects | Adenine - adverse effects | Quinolones - adverse effects | Ritonavir - adverse effects | Adenine - therapeutic use | Quinolones - therapeutic use | Protease Inhibitors - adverse effects | Ritonavir - therapeutic use | Adult | Anti-HIV Agents - therapeutic use | Deoxycytidine - adverse effects | Female | Protease Inhibitors - therapeutic use | Emtricitabine | Adenine - analogs & derivatives | Organophosphonates - therapeutic use | Anti-HIV Agents - adverse effects | Organophosphonates - adverse effects | Drug Therapy, Combination - methods | HIV | Carbamates - adverse effects | HIV Infections - drug therapy | Carbamates - therapeutic use | Viral Load - drug effects | Cobicistat | Deoxycytidine - analogs & derivatives | Adults | Protease inhibitors | Proteases | Antiretroviral drugs | Patient satisfaction | Drug therapy | Laboratories | Human immunodeficiency virus--HIV | Index Medicus
Journal Article
Science (American Association for the Advancement of Science), ISSN 0036-8075, 9/2010, Volume 329, Issue 5996, pp. 1168 - 1174
Human sexual behavior | HIV infections | Antiinfectives | Gels | HIV | RESEARCH ARTICLES | Placebos | Experimentation | AIDS | Infections | Condoms | Science & Technology - Other Topics | Multidisciplinary Sciences | Science & Technology | Infectious diseases | Viral diseases | Viral diseases of the lymphoid tissue and the blood. Aids | Biological and medical sciences | Tropical medicine | Medical sciences | Human viral diseases | HIV Infections - prevention & control | Anti-Infective Agents, Local - therapeutic use | Urban Population - statistics & numerical data | HIV Infections - epidemiology | Humans | Anti-Infective Agents, Local - adverse effects | Drug Resistance, Viral | Administration, Intravaginal | Viral Load | Incidence | Anti-HIV Agents - administration & dosage | Tenofovir | Young Adult | Adenine - adverse effects | HIV-1 - physiology | Adenine - therapeutic use | Adult | Anti-HIV Agents - therapeutic use | Female | Vaginal Creams, Foams, and Jellies | Rural Population - statistics & numerical data | Sexual Behavior | Adenine - analogs & derivatives | Double-Blind Method | Organophosphonates - therapeutic use | HIV-1 - drug effects | Anti-HIV Agents - adverse effects | South Africa - epidemiology | Organophosphonates - adverse effects | Adenine - administration & dosage | Pregnancy | Organophosphonates - administration & dosage | Anti-Infective Agents, Local - administration & dosage | Adolescent | Patient Compliance | Pregnancy Outcome | Prevention | Anti-infective agents | Research | HIV infection | Index Medicus
Journal Article
The Lancet (British edition), ISSN 0140-6736, 2015, Volume 385, Issue 9987, pp. 2606 - 2615
Internal Medicine | Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Humans | Male | Thiazoles - administration & dosage | Carbamates - administration & dosage | Arthralgia - chemically induced | Thiazoles - adverse effects | Sleep Initiation and Maintenance Disorders - chemically induced | Tenofovir | Adenine - adverse effects | Quinolones - adverse effects | Adult | Anti-HIV Agents - therapeutic use | Deoxycytidine - adverse effects | Female | Headache - chemically induced | Emtricitabine | Adenine - analogs & derivatives | Kidney - drug effects | Respiration Disorders - chemically induced | Double-Blind Method | Anti-HIV Agents - adverse effects | Deoxycytidine - administration & dosage | HIV Infections - virology | Organophosphonates - adverse effects | Treatment Outcome | CD4 Lymphocyte Count | Nausea | Adenine - administration & dosage | Organophosphonates - administration & dosage | Bone Density - drug effects | Quinolones - administration & dosage | Carbamates - adverse effects | HIV Infections - drug therapy | Viral Load - drug effects | Cobicistat | Deoxycytidine - analogs & derivatives | Drug Combinations | Medical colleges | Clinical trials | Cross infection | Nosocomial infections | HIV (Viruses) | Drug therapy | Health aspects | HIV infection | Analysis | Antiretroviral drugs | Infections | Acquired immune deficiency syndrome--AIDS | Human immunodeficiency virus--HIV | Index Medicus | Abridged Index Medicus
Journal Article
The Journal of infectious diseases, ISSN 0022-1899, 4/2013, Volume 207, Issue 7, pp. 1157 - 1165
T lymphocytes | HIV/AIDS | Telomeres | Antiretrovirals | HIV | Final causes | Cell lines | Nucleosides | Reverse transcriptase inhibitors | Carts | Disease risks | telomerase | aging | HIV infection | antiretroviral therapy | telomere | Infectious Diseases | Immunology | Life Sciences & Biomedicine | Microbiology | Science & Technology | Fundamental and applied biological sciences. Psychology | Miscellaneous | Infectious diseases | Biological and medical sciences | Medical sciences | Virology | Humans | Middle Aged | Aging - drug effects | Antiretroviral Therapy, Highly Active - adverse effects | Male | Telomere - drug effects | Case-Control Studies | Lamivudine - adverse effects | Reverse Transcriptase Inhibitors - adverse effects | Tenofovir | Young Adult | Telomere Shortening | Adenine - adverse effects | HIV Infections - pathology | Time Factors | Polymerase Chain Reaction | Adult | Deoxycytidine - adverse effects | Female | Telomerase - metabolism | Dideoxynucleosides - adverse effects | Emtricitabine | Adenine - analogs & derivatives | Leukocytes, Mononuclear - drug effects | Zidovudine - adverse effects | Anti-HIV Agents - adverse effects | HIV Infections - virology | Risk Factors | Cells, Cultured | Organophosphonates - adverse effects | HIV - pathogenicity | Enzyme Activation - drug effects | Regression Analysis | Telomere - enzymology | HIV Infections - drug therapy | Leukocytes, Mononuclear - enzymology | Telomerase - antagonists & inhibitors | Deoxycytidine - analogs & derivatives | Complications and side effects | Demographic aspects | Physiological aspects | Aging | Research | Telomerase | Index Medicus | Abridged Index Medicus
Journal Article
Journal of acquired immune deficiency syndromes (1999), ISSN 1525-4135, 05/2007, Volume 45, Issue 1, pp. 34 - 42
Low-density lipoprotein | Women | Highly active antiretroviral therapy | Lipids | High-density lipoprotein | Infectious Diseases | Immunology | Life Sciences & Biomedicine | Science & Technology | Fundamental and applied biological sciences. Psychology | Miscellaneous | Infectious diseases | Microbiology | Viral diseases | Biological and medical sciences | Medical sciences | Human viral diseases | Virology | Cholesterol - blood | Didanosine - adverse effects | Humans | Antiretroviral Therapy, Highly Active - adverse effects | Hispanic Americans - statistics & numerical data | Nevirapine - adverse effects | Tenofovir | Adenine - therapeutic use | Stavudine - therapeutic use | Lamivudine - therapeutic use | Ritonavir - therapeutic use | Dideoxynucleosides - adverse effects | HIV Protease Inhibitors - adverse effects | Adenine - analogs & derivatives | Organophosphonates - therapeutic use | Organophosphonates - adverse effects | HIV Protease Inhibitors - therapeutic use | HIV-1 | Didanosine - therapeutic use | Multivariate Analysis | Lipoproteins, HDL - blood | United States | HIV Seropositivity - drug therapy | Nevirapine - therapeutic use | Lamivudine - adverse effects | Adenine - adverse effects | Ritonavir - adverse effects | Stavudine - adverse effects | Lipids - blood | Adult | Anti-HIV Agents - therapeutic use | Female | Dideoxynucleosides - therapeutic use | Drug Therapy, Combination | HIV Seronegativity | Nelfinavir - therapeutic use | Fasting | Cross-Sectional Studies | Anti-HIV Agents - adverse effects | Benzoxazines - adverse effects | European Continental Ancestry Group - statistics & numerical data | Benzoxazines - therapeutic use | Nelfinavir - adverse effects | African Continental Ancestry Group - statistics & numerical data | Triglycerides - blood | HIV Infections - drug therapy | Indinavir - adverse effects | Lipoproteins, LDL - blood | HIV Infections - metabolism | Indinavir - therapeutic use | Measurement | Complications and side effects | Dosage and administration | Blood lipids | Health aspects | HIV infection | Antiretroviral drugs | Drug therapy | Multivariate analysis | Human immunodeficiency virus--HIV | Index Medicus | AIDS/HIV
Journal Article